The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test. The discovery could improve treatments for prostate cancer by ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

A wide range of top-performing healthcare comms agencies, charities and healthcare communicators claimed the honours at last night’s annual Communiqué Awards. The awards, run every year by PMLive’s ...

Pfizer and Clear Creek Bio have announced a collaboration aiming to advance the discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

This year, due to the COVID-19 pandemic and social distancing requirements, the PMEA Awards event will be streamed live at pmlive.com/pmea2020. After receiving a high ...

The European Union is demanding that AstraZeneca (AZ) delivers 120 million doses of its COVID-19 vaccine by the end of June, threatening financial sanctions if the company fails to meet this target.

Specialist healthcare communications agency GCI Health has promoted Claire Martin to associate director and Laura Starr to associate director and head of creative. Claire will take on further agency ...

French pharma company Servier and biopharma company Oncodesign have reach the first milestone in their collaboration on research and development into new drug candidates for Parkinson’s disease. In a ...

Merck KGaA and Pfizer have staked a claim to the first-line renal cell carcinoma market, with data on a new combination that analyst say could challenge to become a new standard for the disease. The ...